Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, September 6, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Pete Stavropoulos Reiterated (VERA) at Buy and Held Target at $107 on, Sep 6th, 2024
Pete Stavropoulos of Cantor Fitzgerald, Reiterated "Vera Therapeutics, Inc." (VERA) at Buy and Held Target at $107 on, Sep 6th, 2024.
Pete has made no other calls on VERA in the last 4 months.
There are 2 other peers that have a rating on VERA. Out of the 2 peers that are also analyzing VERA, 0 agree with Pete's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Pete
- Anupam Rama of "JP Morgan" Maintained at Buy with Increased Target to $72 on, Tuesday, September 3rd, 2024
- Steven Seedhouse of "Raymond James" Maintained at Strong Buy with Increased Target to $68 on, Friday, May 10th, 2024
